GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Haleon PLC (NYSE:HLN) » Definitions » Interest Coverage

HLN (Haleon) Interest Coverage : 5.17 (As of Jun. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Haleon Interest Coverage?

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income by its Interest Expense. Haleon's Operating Income for the three months ended in Jun. 2024 was $631 Mil. Haleon's Interest Expense for the three months ended in Jun. 2024 was $-122 Mil. Haleon's interest coverage for the quarter that ended in Jun. 2024 was 5.17. The higher the ratio, the stronger the company's financial strength is.

The historical rank and industry rank for Haleon's Interest Coverage or its related term are showing as below:

HLN' s Interest Coverage Range Over the Past 10 Years
Min: 4.82   Med: 34.5   Max: 106.53
Current: 4.97


HLN's Interest Coverage is ranked worse than
69.7% of 660 companies
in the Drug Manufacturers industry
Industry Median: 13.625 vs HLN: 4.97

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.


Haleon Interest Coverage Historical Data

The historical data trend for Haleon's Interest Coverage can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

Haleon Interest Coverage Chart

Haleon Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Interest Coverage
34.50 106.53 102.37 6.56 4.82

Haleon Quarterly Data
Dec19 Dec20 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Interest Coverage Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.64 1.87 6.75 5.17 7.83

Competitive Comparison of Haleon's Interest Coverage

For the Drug Manufacturers - Specialty & Generic subindustry, Haleon's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Haleon's Interest Coverage Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Haleon's Interest Coverage distribution charts can be found below:

* The bar in red indicates where Haleon's Interest Coverage falls into.



Haleon Interest Coverage Calculation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:

If Interest Expense is negative and Operating Income is positive, then

Interest Coverage=-1* Operating Income /Interest Expense

Else if Interest Expense is negative and Operating Income is negative, then

The company did not have earnings to cover the interest expense.

Else if Interest Expense is 0 and Long-Term Debt & Capital Lease Obligation is 0, then

The company had no debt (1).


Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Haleon's Interest Coverage for the fiscal year that ended in Dec. 2023 is calculated as

Here, for the fiscal year that ended in Dec. 2023, Haleon's Interest Expense was $-524 Mil. Its Operating Income was $2,527 Mil. And its Long-Term Debt & Capital Lease Obligation was $11,139 Mil.

Interest Coverage=-1* Operating Income (A: Dec. 2023 )/Interest Expense (A: Dec. 2023 )
=-1*2526.582/-524.051
=4.82

Haleon's Interest Coverage for the quarter that ended in Jun. 2024 is calculated as

Here, for the three months ended in Jun. 2024, Haleon's Interest Expense was $-122 Mil. Its Operating Income was $631 Mil. And its Long-Term Debt & Capital Lease Obligation was $9,424 Mil.

Interest Coverage=-1* Operating Income (Q: Jun. 2024 )/Interest Expense (Q: Jun. 2024 )
=-1*631.043/-122.137
=5.17

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's Financial Strength is.


Haleon  (NYSE:HLN) Interest Coverage Explanation

Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.

Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .


Haleon Interest Coverage Related Terms

Thank you for viewing the detailed overview of Haleon's Interest Coverage provided by GuruFocus.com. Please click on the following links to see related term pages.


Haleon Business Description

Traded in Other Exchanges
Address
The Heights, Building 5, First Floor, Surrey, Weybridge, GBR, KT13 0NY
Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon's brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.